Shah Gaurav 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed May 20, 2025
Insider Transaction Report
Form 4
Shah Gaurav
CEO
Transactions
- Sale
Common Stock
2025-05-16$6.53/sh−3,621$23,638→ 789,059 total
Holdings
- 198,341(indirect: By Trust)
Common Stock
- 207,897(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
- [F2]The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.